STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENZN
  4. [EFFECT] ENZON PHARMACEUTICALS, INC. SEC Filing

[EFFECT] ENZON PHARMACEUTICALS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 30, 2026 4:30 P.M.
Form: S-4
CIK: 0000727510
Company Name: ENZON PHARMACEUTICALS, INC.
File Number: 333-293019

Source: View Original Filing on SEC EDGAR

Stock ENZN logo
Enzon Pharma

OTC:ENZN

ENZN Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

ENZN Latest News

Jan 30, 2026
Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger
Oct 24, 2025
Enzon and Viskase Announce Amendment to Merger Agreement
Jun 20, 2025
Enzon and Viskase Enter into Merger Agreement

ENZN Latest SEC Filings

Jan 30, 2026
[SCHEDULE 13D/A] ENZON PHARMACEUTICALS, INC. Amended Major Shareholder Report
Jan 30, 2026
[SC TO-I] ENZON PHARMACEUTICALS, INC. Issuer Tender Offer
Jan 30, 2026
[424B3] ENZON PHARMACEUTICALS, INC. Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 30, 2026
[S-4/A] ENZON PHARMACEUTICALS, INC. Amended Business Combination Registration
Jan 30, 2026
[8-K] ENZON PHARMACEUTICALS, INC. Reports Material Event

ENZN Stock Data

5.94M
30.11M
10.84%
48.58%
0.59%
Biotechnology
Healthcare
Link
United States
Cranford